Φορτώνει......
New developments in the treatment of chronic myeloid leukemia and Philadelphia-positive acute lymphoblastic leukemia
Although imatinib revolutionized the management of chronic myeloid leukemia (CML), recent data indicate a transformation in the treatment approach likely in the near future. The superiority of second-generation tyrosine kinase inhibitors (TKIs) over imatinib in newly diagnosed disease has been recog...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Leuk Lymphoma |
|---|---|
| Κύριοι συγγραφείς: | , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
2011
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5681224/ https://ncbi.nlm.nih.gov/pubmed/21299461 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/10428194.2010.546917 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|